Breast cancer often relapses in distant organs even when complete regression of primary tumors is achieved after initial ...

Individuals with ulcerative colitis have an increased risk for certain types of cancer based on age, instead of treatment type.

Objectives In December 2018, China launched national volume-based procurement (NVBP) to negotiate drug prices with manufacturers. Gefitinib was one of the 25 pilot drugs, which is used for treatment ...

Scientists have developed a tool that can predict how bowel cancer adapts to treatment—helping researchers to design new personalized drugs that will keep patients living well for longer.

Abstract Targeted monotherapies for cancer often fail due to inherent or acquired drug resistance. By aiming at multiple targets simultaneously, drug combinations can produce synergistic interactions ...

We then compared the synergy of a combination of drugs A and B in relation to the monotherapy sensitivity to both drugs, only one drug, or neither drug. In Test Set 1, DIPx outperformed TAJI-M in all ...

Recent breakthroughs by The Institute of Cancer Research in London and the University of Virginia in the U.S. could cut drug development times in half.

Cancer drug funding decisions are becoming progressively more difficult because of the increasing numbers of drugs, their escalating costs, 31 and the uncertainty of their clinical benefit in the real ...

BOSTON, MASSACHUSETTS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral ...

The price of drugs newly added to China's reimbursement list - a figure negotiated with drugmakers - will drop by 63% on average, state news agency Xinhua reported, adding that 91 new drugs had ...

The research group developed a combined score, named UAB36, using the 36 genes most linked to drug resistance. They found that the polygenic score UAB36 showed superior correlation with relative ...

“We report a prospective genetic landscape of drug resistance mechanisms in cancer, one of the most comprehensive functional investigations of genetic drug resistance mechanisms to date ...